Mercator Medical S.A. (MRC) — Capital Reinvestment Ratio

Latest as of September 2025: 0.25x

Mercator Medical S.A. (MRC) has a Capital Reinvestment Ratio of 0.25x as of September 2025, meaning it reinvests 0% of its operating cash flow (zł46.48 Million) in capital expenditures (zł11.67 Million). See net asset quality index of Mercator Medical S.A. to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.25x
Capex / Operating Cash Flow

Operating Cash Flow

zł46.48 Million
PLN

Capital Expenditures

zł11.67 Million
PLN

Data as of

Sep 2025
Most recent filing

Mercator Medical S.A. Capital Reinvestment Ratio (2012–2022)

This chart tracks Mercator Medical S.A.'s Capital Reinvestment Ratio across 10 annual periods. Check Mercator Medical S.A. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Mercator Medical S.A. (2012–2022)

Year-by-year Capital Reinvestment Ratio for Mercator Medical S.A. from 2012 to 2022. For live market cap and broader valuation context, see Mercator Medical S.A. (MRC) total market value.

Year Reinvestment Ratio Operating CF (PLN) Capital Expenditures YoY Change
2022 2.69x zł40.79 Million zł109.65 Million ▲ +665.0%
2021 0.35x zł503.00 Million zł176.75 Million ▲ +1515.7%
2020 0.02x zł712.47 Million zł15.49 Million ▼ -94.6%
2019 0.40x zł38.53 Million zł15.57 Million ▼ -87.0%
2017 3.10x zł23.67 Million zł73.41 Million ▲ +156.3%
2016 1.21x zł16.61 Million zł20.10 Million ▼ -16.5%
2015 1.45x zł7.88 Million zł11.41 Million ▼ -30.6%
2014 2.09x zł12.56 Million zł26.24 Million ▼ -49.7%
2013 4.16x zł1.92 Million zł7.99 Million ▲ +643.6%
2012 0.56x zł7.57 Million zł4.23 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow